Physician profile
Andrew Star
NPI 1033192497
$506,652.80
in general payments reported to CMS, 2019-2025
13 companies · $8,369 in 2025
The $8,369 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $90K · 2021: $141K · 2022: $118K · 2023: $46K · 2024: $39K · 2025: $8,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $88K · Travel and Lodging: $3,987 · Food and Beverage: $1,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $87,915.10 |
| Travel and Lodging | $3,987.42 |
| Food and Beverage | $1,587.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $417,837.55 | 2019-2025 | Attune, Sigma, Solution System |
| Stryker Corporation | $74,494.09 | 2019-2025 | Mako, Insignia, Triathlon |
| Depuy Synthes Products, INC. | $12,073.70 | 2020-2022 | |
| Depuy Synthes Sales INC. | $1,838.85 | 2019-2025 | Inhance, Attune, Velys |
| Radlink, INC | $147.71 | 2019 | |
| Siemens Medical Solutions USA, INC. | $92.50 | 2021 | |
| Zimmer Biomet Holdings, INC. | $57.60 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Si-Bone, INC. | $29.30 | 2022 | |
| Medtronic, INC. | $22.81 | 2025 | Intellis Adaptivestim |
| Convatec INC. | $18.99 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $18.49 | 2020 | |
| Globus Medical, INC. | $11.15 | 2021 | |
| Heraeus Medical, LLC. | $10.06 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,912,500.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Star listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.